推薦產品
一般說明
Anti-FAP, mouse monoclonal, clone F11-24, recognizes fibroblast activation protein in human. It is validated for use in flow cytometry, immunoprecipitation, & immunohistochemistry (frozen sections).
Protein A purified mouse monoclonal antibody. Recognizes human fibroblast activation protein (FAP).
Recognizes fibroblast activation protein (FAP).
免疫原
HEK293 cells transfected with an expression vector encoding full-length human FAP
Human
應用
Flow Cytometry (see comments)
Frozen Sections (1-5 µg/ml)
Immunoprecipitation (see comments)
Frozen Sections (1-5 µg/ml)
Immunoprecipitation (see comments)
包裝
Please refer to vial label for lot-specific concentration.
警告
Toxicity: Standard Handling (A)
外觀
In PBS.
重構
Following initial thaw, aliquot and freeze (-20°C).
分析報告
Positive Control
Reactive human fibroblasts, glucagon-producing A cells
Reactive human fibroblasts, glucagon-producing A cells
其他說明
Does not react with resting fibroblasts of normal organ mesenchyme or parenchymal cells, except for the glucagon-producing A cells found in the pancreatic islets. This antibody has also been reported to work for flow cytometry and immunoprecipitation. Antibody should be titrated for optimal results in individual systems.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到適合的產品?
試用我們的產品選擇工具.
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 1
閃點(°F)
Not applicable
閃點(°C)
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
Methods in molecular biology (Clifton, N.J.), 1619, 263-301 (2017-07-05)
DotScan antibody microarrays were initially developed for the extensive surface profiling of live leukemia and lymphoma cells. DotScan's diagnostic capability was validated with an extensive clinical trial using mononuclear cells from the blood or bone marrow of leukemia or lymphoma
Journal for immunotherapy of cancer, 8(2) (2020-07-04)
The costimulatory receptor 4-1BB (CD137, TNFRSF9) plays an important role in sustaining effective T cell immune responses and is investigated as target for cancer therapy. Systemic 4-1BB directed therapies elicit toxicity or low efficacy, which significantly hampered advancement of 4-1BB-based
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務